» Articles » PMID: 17174996

Phenylalanine(90) and Phenylalanine(93) Are Crucial Amino Acids Within the Estrogen Binding Site of the Human UDP-glucuronosyltransferase 1A10

Overview
Journal Steroids
Publisher Elsevier
Specialty Biochemistry
Date 2006 Dec 19
PMID 17174996
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Human UDP-glucuronosyltransferase 1A10 has been identified as the major isoform involved in the biotransformation of a wide range of phenolic substrates, including native estrogens and their oxidized metabolites. Our recent studies point to the F(90)-M(91)-V(92)-F(93) amino acid motif of UGT1A10, which was identified using photoaffinity labeling followed by LC-MS/MS analysis, as a key determinant of the binding of phenolic substrates. In this report, we have evaluated the role of F(90), V(92), and F(93) in the recognition of estrogens by UGT1A10 using site-directed mutagenesis. Kinetic studies using five mutants revealed that F(90) and F(93) are critical residues for the recognition of all estrogen substrates. The substitution of F(90) with alanine totally abolished the activity of this enzyme toward all the estrogens investigated. Overall, sequential removal for the aromatic ring (F to L) and of the hydrophobic chain (F to A and V to A) from amino acids 90, 92, and 93 effectively alters estrogen recognition. This demonstrates that individual features of the native and hydroxylated estrogens determine the specific binding properties of the compound within the binding site of the human UGT1A10 and the mutants. The resulting activities are completely abolished, unchanged, increased, or decreased depending on the structures of both the mutant and the substrate. The novel identification of UGT1A10 as the major isoform involved in the glucuronidation of all estrogens and the discovery of the importance of the FMVF motif in the binding of steroids will help to elucidate the molecular mechanism of glucuronidation, resulting in the design of more effective estrogen-based therapies.

Citing Articles

Unsymmetrical Bisacridines' Interactions with ABC Transporters and Their Cellular Impact on Colon LS 174T and Prostate DU 145 Cancer Cells.

Pawlowska M, Kulesza J, Paluszkiewicz E, Augustin E, Mazerska Z Molecules. 2024; 29(23).

PMID: 39683740 PMC: 11644013. DOI: 10.3390/molecules29235582.


Enhanced Activity of P4503A4 and UGT1A10 Induced by Acridinone Derivatives C-1305 and C-1311 in MCF-7 and HCT116 Cancer Cells: Consequences for the Drugs' Cytotoxicity, Metabolism and Cellular Response.

Pawlowska M, Kwasniewska A, Mazerska Z, Augustin E Int J Mol Sci. 2020; 21(11).

PMID: 32486425 PMC: 7312182. DOI: 10.3390/ijms21113954.


Prevalence of the promoter polymorphism and breast cancer risk among African American women in Memphis, TN.

Smith A, Cropp C, Vidal G, Pritchard E, Cordero J, Simpson C Cancer Health Disparities. 2019; 3:e1-e12.

PMID: 31485577 PMC: 6724729. DOI: 10.9777/chd.2019.1015.


Characterization of UDP-glucuronosyltransferase (UGT1A1) Promoter Polymorphisms and Gene Expression on Ethnicity, Stage of Disease, and Menopausal Status in Breast Cancer.

Starlard-Davenport A, Word B, Lyn-Cook B J Drug Metab Toxicol. 2018; 2012(Suppl 4).

PMID: 30349745 PMC: 6195800. DOI: 10.4172/2157-7609.S4-001.


Altered metabolism of synthetic cannabinoid JWH-018 by human cytochrome P450 2C9 and variants.

Patton A, Seely K, Yarbrough A, Fantegrossi W, James L, McCain K Biochem Biophys Res Commun. 2018; 498(3):597-602.

PMID: 29522717 PMC: 6425723. DOI: 10.1016/j.bbrc.2018.03.028.


References
1.
Raftogianis R, CREVELING C, Weinshilboum R, Weisz J . Estrogen metabolism by conjugation. J Natl Cancer Inst Monogr. 2000; (27):113-24. DOI: 10.1093/oxfordjournals.jncimonographs.a024234. View

2.
Chouinard S, Tessier M, Vernouillet G, Gauthier S, Labrie F, Barbier O . Inactivation of the pure antiestrogen fulvestrant and other synthetic estrogen molecules by UDP-glucuronosyltransferase 1A enzymes expressed in breast tissue. Mol Pharmacol. 2005; 69(3):908-20. DOI: 10.1124/mol.105.015891. View

3.
Liehr J . Role of DNA adducts in hormonal carcinogenesis. Regul Toxicol Pharmacol. 2001; 32(3):276-82. DOI: 10.1006/rtph.2000.1432. View

4.
Little J, Williams L, Xu J, Radominska-Pandya A . Glucuronidation of the dietary fatty acids, phytanic acid and docosahexaenoic acid, by human UDP-glucuronosyltransferases. Drug Metab Dispos. 2002; 30(5):531-3. DOI: 10.1124/dmd.30.5.531. View

5.
Kurkela M, Garcia-Horsman J, Luukkanen L, Morsky S, Taskinen J, Baumann M . Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than other UGTs and was purified as an active dimeric enzyme. J Biol Chem. 2002; 278(6):3536-44. DOI: 10.1074/jbc.M206136200. View